44.VALUE OF PHIGFBP-1 TEST IN PREDICTING PREMATURE LABOR AT NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY
Main Article Content
Abstract
Objective: To describe the result of PhIGFBP-1 test in the diagnosis of pre-term birth at the National Hospital of Obstetrics and Gynecology.
Methodology: A cross-sectional and prospective descriptive study was conducted. Testing PhIGFBP-1 was performed on 158 pregnant women with a diagnosis of threatened preterm labor admitted to the Department of Obstetrics Pathology, National Hospital of Obstetrics and Gynecology, followed up for 14 days and recorded whether patients gave birth or not within 14 days.
Results: 33 out of 158 pregnant women had preterm birth, of which 21 pregnant women (13.3%) had preterm birth within 7 days of admission, and 12 pregnant women (7.6%) had preterm birth within the next 7-14 days. The sensitivity, specificity, positive diagnostic value, and negative diagnostic value of the PhIGFBP-1 test were 75.8%, 77.6%, 47.2%, and 92.4%, respectively.
Conclusions: The test to determine the presence of PhIGFBP-1 in cervical fluid has high value in the diagnosis in cases of preterm pregnancy with patients having signs of threatened preterm labor. It can be considered as a screening measure to limit and minimize unnecessary medical interventions in preterm pregnant women
Article Details
Keywords
PhIGFBP-1, pre-term birth
References
[2] Ohuma E.O et al, National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis, The Lancet, vol. 402, No. 10409, pp. 1261-1271, Oct. 2023, doi: 10.1016/S0140-6736(23)00878-4.
[3] Hadzi M, Maier J.T, Helmer H, Hellmeyer L, Markova A.D, Poposka A, Comparison of PAMG-1 and PhIGFBP-1 Tests for the Prediction of Preterm Delivery in Patients with Preterm Labor, Open J. Obstet. Gynecol., vol. 7, No. 3, Art. No. 3, Mar. 2017, doi: 10.4236/ojog.2017.73037.
[4] Riboni F, Vitulo A, Dell’avanzo M, Plebani M, Battagliarin G, Paternoster D, Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin, Arch. Gynecol. Obstet., vol. 284, No. 6, pp. 1325-1329, Dec. 2011, doi: 10.1007/s00404-011-1839-4.
[5] Di Renzo G.C et al, Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth, J. Matern-Fetal Neonatal Med. Off. J. Eur. Assoc. Perinat. Med. Fed. Asia Ocean. Perinat. Soc. Int. Soc. Perinat. Obstet., vol. 24, No. 5, pp. 659-667, May 2011, doi: 10.3109/14767058.2011.553694.
[6] Iams J.D, Prediction and early detection of preterm labor, Obstet. Gynecol., vol. 101, No. 2, pp. 402-412, Feb. 2003, doi: 10.1016/s0029-7844(02)02505-x.
[7] Tanir H.M, Sener T, Yildiz Z, Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes, J. Obstet. Gynaecol. Res., vol. 35, No. 1, pp. 66-72, Feb. 2009, doi: 10.1111/j.1447-0756.2008.00833.x.
[8] Altinkaya O, Gungor T, Ozat M, Danisman N, Mollamahmutoglu L, Cervical phosphorylated insulin-like growth factor binding protein-1 in prediction of preterm delivery, Arch. Gynecol. Obstet., vol. 279, No. 3, pp. 279-283, Mar. 2009, doi: 10.1007/s00404-008-0703-7.
[9] Bruijn M.M.C et al, Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement, Eur. J. Obstet. Gynecol. Reprod. Biol., vol. 206, pp. 220-224, Nov. 2016, doi: 10.1016/j.ejogrb.2016.09.018.